Browse by People

McDonald, E (2015) Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Chronic Myeloid Leukaemia. PhD thesis, University of Liverpool.

Collapse authors list.
Hochhaus, A, Baccarani, M, Silver, RT, Schiffer, C, Apperley, JF, Cervantes, F, Clark, RE ORCID: 0000-0002-1261-3299, Cortes, JE, Deininger, MW, Guilhot, F et al (show 24 more authors) , Hjorth-Hansen, H, Hughes, TP, Janssen, JJWM, Kantarjian, HM, Kim, DW, Larson, RA, Lipton, JH, Mahon, FX, Mayer, J, Nicolini, F, Niederwieser, D, Pane, F, Radich, JP, Rea, D, Richter, J, Rosti, G, Rousselot, P, Saglio, G, Saussele, S, Soverini, S, Steegmann, JL, Turkina, A, Zaritskey, A and Hehlmann, R (2020) European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia. LEUKEMIA, 34 (4). pp. 966-984.

Collapse authors list.
Steegmann, JL, Baccarani, M, Breccia, M, Casado, LF, Garcia-Gutierrez, V, Hochhaus, A, Kim, D-W, Kim, TD, Khoury, HJ, Le Coutre, P et al (show 8 more authors) , Mayer, J, Milojkovic, D, Porkka, K, Rea, D, Rosti, G, Saussele, S, Hehlmann, R and Clark, RE ORCID: 0000-0002-1261-3299 (2016) European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia. LEUKEMIA, 30 (8). pp. 1648-1671.

Lucas, CM ORCID: 0000-0001-6674-7535, Milani, M, Butterworth, M, Carmell, N, Scott, LJ, Clark, RE ORCID: 0000-0002-1261-3299, Cohen, GM and Varadarajan, S ORCID: 0000-0002-8827-6567 (2016) High CIP2A levels correlate with an antiapoptotic phenotype that can be overcome by targeting BCL-X-L in chronic myeloid leukemia. LEUKEMIA, 30 (6). pp. 1273-1281.

Clark, RE ORCID: 0000-0002-1261-3299 and Clark RE, Polydoros F, Apperley JF, Milojkovic D, Rothwell K, Po, (2019) Initial reduction of therapy improves the chance of successful complete treatment discontinuation in chronic myeloid leukaemia: Final results of the British DESTINY Study. Lancet Haematology.

Collapse authors list.
Burnett, AK, Russell, NH, Hills, RK, Kell, J, Nielsen, OJ, Dennis, M, Cahalin, P, Pocock, C, Ali, S, Burns, S et al (show 3 more authors) , Freeman, S, Milligan, D and Clark, RE ORCID: 0000-0002-1261-3299 (2017) A comparison of clofarabine with Ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia. Leukemia, 31 (2). pp. 310-317.

Collapse authors list.
Horne, GA, Stobo, J, Kelly, C, Mukhopadhyay, A, Latif, AL, Dixon-Hughes, J, McMahon, L, Cony-Makhoul, P, Byrne, J, Smith, G et al (show 13 more authors) , Koschmieder, S, BrUemmendorf, TH, Schafhausen, P, Gallipoli, P, Thomson, F, Cong, W, Clark, RE ORCID: 0000-0002-1261-3299, Milojkovic, D, Helgason, GV, Foroni, L, Nicolini, FE, Holyoake, TL and Copland, M (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. LEUKEMIA, 34 (7). pp. 1775-1786.